Christopher Aled Chamberlain

6PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 01, 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma.

Arianna Draghi, Mario Presti, Agnete W P Jensen

|Aug 15, 2022
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy.

Morten Nielsen, Mario Presti, Zsofia Sztupinszki

|Oct 05, 2021
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types.

Anders Handrup Kverneland, Christopher Aled Chamberlain, Troels Holz Borch

|Nov 17, 2020
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma.

Aishwarya Gokuldass, Arianna Draghi, Krisztian Papp

|Nov 09, 2020
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.

Mario Presti, Marie Christine Wulff Westergaard, Arianna Draghi

|Jul 13, 2018
β-Lactamase Tools for Establishing Cell Internalization and Cytosolic Delivery of Cell Penetrating Peptides.

Shane R Stone, Tatjana Heinrich, Suzy M Juraja

Pageof 1

Frequent Collaborators

4 joint publications

Arianna Draghi

4 joint publications

Marco Donia

3 joint publications

Mario Presti

3 joint publications

Morten Nielsen